I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Rivaroxaban Compared with Standard Anticoagulants for the T..:
Male, C
;
Lensing, A. W. A
;
Palumbo, J. S
...
Rivaroxaban Compared with Standard Anticoagulants for the Treatment of Acute Venous Thromboembolism in Children: a Randomised, Controlled, Phase 3 Trial / C. Male, A. W. A. Lensing, J. S. Palumbo et al. // The Lancet Haematology. — 2020. — Vol. 7. — Iss. 1. — P. e18-e27.. , 2020
Link:
http://elar.urfu.ru/handle/10995/111230
RT Journal T1
Rivaroxaban Compared with Standard Anticoagulants for the Treatment of Acute Venous Thromboembolism in Children: a Randomised, Controlled, Phase 3 Trial
UL https://suche.suub.uni-bremen.de/peid=base-fturalfuniv:oai:elar.urfu.ru:10995_111230&Exemplar=1&LAN=DE A1 Male, C A1 Lensing, A. W. A A1 Palumbo, J. S A1 Kumar, R A1 Nurmeev, I A1 Hege, K A1 Bonnet, D A1 Connor, P A1 Hooimeijer, H. L A1 Torres, M A1 Chan, A. K. C A1 Kenet, G A1 Holzhauer, S A1 Santamaría, A A1 Amedro, P A1 Chalmers, E A1 Simioni, P A1 Bhat, R. V A1 Yee, D. L A1 Lvova, O A1 Beyer-Westendorf, J A1 Biss, T. T A1 Martinelli, I A1 Saracco, P A1 Peters, M A1 Kállay, K A1 Gauger, C. A A1 Massicotte, M. P A1 Young, G A1 Pap, A. F A1 Majumder, M A1 Smith, W. T A1 Heubach, J. F A1 Berkowitz, S. D A1 Thelen, K A1 Kubitza, D A1 Crowther, M A1 Prins, M. H A1 Monagle, P A1 Molinari, A. C A1 Nowak, Göttl, U A1 Chain, J A1 Robertson, J A1 Thom, K A1 Streif, W A1 Schwarz, R A1 Schmitt, K A1 Grangl, G A1 Van Damme, A A1 Maes, P A1 Labarque, V A1 Petrilli, A A1 Loggeto, S A1 Azeka, E A1 Brandao, L A1 Le, D A1 Sabapathy, C A1 Giordano, P A1 Wu, R A1 Ding, J A1 Huang, W A1 Mao, J A1 Lähteenmäki, P A1 Decramer, S A1 Bernig, T A1 Chada, M A1 Chan, G A1 Kally, K A1 Nolan, B A1 Revel-Vilk, S A1 Tamary, H A1 Levin, C A1 Tormene, D A1 Abbattista, M A1 Artoni, A A1 Ikeyama, T A1 Inuzuka, R A1 Yasukochi, S A1 Morales Soto, M A1 Solis Labastida, K. A A1 Suijker, M. H A1 Bartels, M A1 Tamminga, R. Y A1 Van Ommen, C. H A1 Te Loo, D. M A1 Anjos, R A1 Zubarovskaya, L A1 Popova, N A1 Samochatova, E A1 Belogurova, M A1 Svirin, P A1 Shutova, T A1 Lebedev, V A1 Barbarash, O A1 Koh, P. L A1 Mei, J. C A1 Podracka, L A1 Berrueco, R A1 Fernandez, M. F A1 Frisk, T A1 Grunt, S A1 Rischewski, J A1 Albisetti-Pedroni, M A1 Antmen, A A1 Tokgoz, H A1 Karakas, Z A1 Motwani, J A1 Williams, M A1 Grainger, J A1 Payne, J A1 Richards, M A1 Baird, S A1 Bhatnagar, N A1 Aramburo, A A1 Crary, S A1 Wynn, T A1 Carpenter, S A1 Ahuja, S A1 Goldenberg, N A1 Woods, G A1 Godder, K A1 Scott-Emuakpor, A A1 Roach, G A1 Raffini, L A1 Shah, N A1 Shah, S A1 Thornburg, C A1 Zia, A A1 Berkow, R PB Elsevier Ltd; Elsevier BV YR 2020 K1 ANTICOAGULANT AGENT K1 ANTIVITAMIN K K1 FONDAPARINUX K1 HEPARIN K1 LOW MOLECULAR WEIGHT HEPARIN K1 RIVAROXABAN K1 ADOLESCENT K1 ANTICOAGULATION K1 ARTICLE K1 BLEEDING K1 CHILD K1 CONTROLLED STUDY K1 DISEASE BURDEN K1 DRUG EFFICACY K1 DRUG SAFETY K1 FEMALE K1 FOLLOW UP K1 HUMAN K1 INFANT K1 INTENTION TO TREAT ANALYSIS K1 MAJOR CLINICAL STUDY K1 MALE K1 MULTICENTER STUDY K1 OPEN STUDY K1 PHASE 3 CLINICAL TRIAL K1 PRIORITY JOURNAL K1 RANDOMIZED CONTROLLED TRIAL K1 TREATMENT OUTCOME K1 VENOUS THROMBOEMBOLISM K1 CLINICAL TRIAL K1 PRESCHOOL CHILD K1 RISK FACTOR K1 ANTICOAGULANTS K1 PRESCHOOL K1 HUMANS JF Rivaroxaban Compared with Standard Anticoagulants for the Treatment of Acute Venous Thromboembolism in Children: a Randomised, Controlled, Phase 3 Trial / C. Male, A. W. A. Lensing, J. S. Palumbo et al. // The Lancet Haematology. — 2020. — Vol. 7. — Iss. 1. — P. e18-e27. LK http://elar.urfu.ru/handle/10995/111230 DO http://elar.urfu.ru/handle/10995/111230 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)